Dr. Lucio van Rooijen

Several companies, research institutions and funds in Life Sciences / BioPharma.

Innovative enzymatic debrider for improved healing of severe burn wounds and chronic wounds (like diabetic foot and open leg). Spin off from Smith & Nephew Inc. with NLC Ventures Netherlands bv.

Provider of the unique assay to identify the cause of Drug Induced Liver Injury. DILI is among the main causes of termination of drug development and market withdrawal, which can often be avoided. Also developing companion diagnostics. General management, fund raising and international commercial roll-out.

Business process outsourcing and consulting company offering the full breadth of pharmacovigilance, regulatory affairs, GxP audits, market intelligence, market access and business development services in CIS and Europe. HQ in Riga, Latvia, with subsidiaries in Kiev, Ukraine, Moscow, Russia and opening in Milan, Italy.

One of the first companies to enter the sector of Rare Diseases in Europe. Established, managed and drove the full organization and business in Germany. Launched and pre-marketing of several products.

World’s first and premier global management consulting firm. Linking strategy, technology and innovation. Asked by worldwide head of Healthcare / Life Science to advise the incoming head DACH/CE in business development. Generated clients and developed several leads at C-level in BioPharmaceutical / Life Science companies.

Ground-breaking biotech company in drug targeting and therapy of brain diseases and of PML. Build a well funded and structured company from a high level science project.

One of the world’s first strategic life-sciences, nutrition and wellness-focused venture capital funds, with $1.5 billion under management, formed with the support of Nestlé. Performed and managed investments and restructured portfolio company.

Interim manager, contractor and advisor in general management, corporate and business development, fund-raising and investments. Build company/organization with up to 10 freelance advisors. Performed for >70 companies, institutions and investment funds in the High-Tech and Life Sciences industries in Europe, USA, India, South Korea, Australia.

One of the first DNA diagnostics companies.

VC funded mid-size bio-pharma company, Protein therapeutics for spinal cord injury. Structured, focussed, scrutinized organization. Successfully sold.

Pharmaceutical contract sales force company. Tripled the turn-over and number of clients.

Established, built and managed the technology office subsidiary of the private University of Witten/Herdecke. Innovation broker.

Manager Central Americas, Bayer AG, Leverkusen, Germany. Marketing and Sales, Bayer plc, Newbury, UK. International Project Manager, Bayer AG, Wuppertal, Germany. Staff to the Head of Pharmaceutical Research, Bayer AG, Wuppertal, Germany. Laboratory Head, CNS, Troponweke GmbH & Co KG (Bayer AG group), Cologne, Germany.